spacer
home > ict > autumn 2016 > the patient chronicle
PUBLICATIONS
International Clinical Trials

The Patient Chronicle

Electronic health records (EHRs) are longitudinal, digital registers of patient health information that can include patient demographics, progress notes, medications, vital signs, past medical history, immunisations, laboratory data and radiology reports (1). Every patient interaction with a healthcare provider produces data; EHRs can store this information and capture the health of a patient across time. The widespread adoption of EHRs is generating comprehensive quantitative and qualitative datasets that could provide many advantages for patients and healthcare companies, but that are also associated with certain obstacles.

Potential Gains


EHRs offer numerous benefits that could possibly transform healthcare, and significantly enhance clinical decisions and patient outcomes. They strengthen healthcare delivery, reduce costs and enable clinicians to make well-informed treatment decisions quickly and safely.

For example, patient safety might be improved when EHRs maintain a record of medications and allergies. When data are accurately inputted into an EHR, the clinician is then able to check for problems such as potential prescribing of conflicting drugs. This lowers the incidence of medical errors, as well as avoids unnecessary patient concerns and additional treatment costs that might be incurred in the event of drug interactions (2). The utilisation of EHRs could also identify patients who are due for preventative visits and screenings, meaning earlier diagnosis and possible hindrance of disease development. In the US, for instance, EHRs can provide these benefits through the following functionalities: clinical decision support tools, computerised physician order entry systems and health information exchange (3).

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Professor Martin Gibson is Chief Executive of NorthWest EHealth, Director of the National Institute for Health Research in Clinical Research for Greater Manchester and Research and Informatics Director for the Greater Manchester Academic Health Science Network. He is also a Consultant Doctor specialising in diabetes and lipid disorders at the Salford Royal NHS Foundation Trust, where he was formerly R&D Director of both the acute and primary care trusts.
spacer
Martin Gibson
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Turkish Cargo keeps growing in the first quarter of 2019

Maintaining its accomplished operations from Ataturk and Istanbul airports as "Dual Hub", the global brand of Turkish Cargo continued its strong growth momentum during the first quarter of the year despite the shrinkage of the global air cargo sector.
More info >>

White Papers

The EC Definition of a Nanomaterial - Potential Measurement Methodologies

NanoSight

In October 2011 the European Commission published a definition of Nanomaterials. This move followed more than six years of scientific consideration of the potential toxicological and environmental challenges posed by engineered nanomaterials.
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement